Fanconi Syndrome: Diagnosis and Management
Diagnose Fanconi syndrome by demonstrating the characteristic triad of glucosuria (with normal serum glucose), generalized aminoaciduria, and phosphaturia, along with type II renal tubular acidosis, and immediately identify the underlying cause—cystinosis in children or drug toxicity in adults—to guide definitive treatment. 1
Diagnostic Approach
Essential Laboratory Investigations
When Fanconi syndrome is suspected, obtain the following studies simultaneously:
Blood tests:
- Blood urea nitrogen, creatinine, and electrolytes (including bicarbonate to assess for type II RTA)
- Calcium and phosphate levels
- Blood glucose (to confirm normoglycemia despite glucosuria)
- Uric acid 2
Urine studies:
- Glucose (glucosuria with normal serum glucose is pathognomonic)
- Amino acids (generalized aminoaciduria, not selective)
- Calcium and phosphate
- Calcium:creatinine ratio
- Tubular reabsorption of phosphate calculation
- Total protein, albumin, or β2-microglobulin
- Uric acid 2
Additional workup:
- Renal ultrasound to assess for nephrocalcinosis, cysts, or architectural abnormalities 2
- Bone radiographs (wrist, chest) and densitometry if hypophosphatemic rickets is suspected 2
Critical Diagnostic Pitfall
Urinary β2-microglobulin and α1-microglobulin are highly sensitive markers for proximal tubular dysfunction and should be measured when Fanconi syndrome is suspected, particularly in drug-induced cases. Elevations can be dramatic (e.g., β2-MG >49,000 μg/L, normal <300 μg/L) and normalize rapidly with appropriate treatment 3. This is especially useful when the diagnosis is unclear or when monitoring treatment response.
Identifying the Underlying Cause
In Children
Cystinosis is the principal cause and should be investigated first through genetic testing or slit-lamp examination for corneal cystine crystals 1. Other inherited metabolic disorders to consider include:
- Tyrosinemia type I (check succinylacetone in urine)
- Glycogen storage disease type XI (Fanconi-Bickel syndrome—look for postprandial hyperglycemia and chronic diarrhea) 4
- Wilson's disease, galactosemia, hereditary fructose intolerance 5
In Adults
Medication-induced Fanconi syndrome is the predominant cause 1. The most common culprits include:
- Tenofovir disoproxil fumarate (TDF): Duration of use before FS onset ranges from 6 weeks to 11 years; concomitant ritonavir increases risk 6
- Adefovir: Can cause severe FS with marked elevations in urinary tubular markers 3
- Cidofovir: Associated with severe cases requiring long-term electrolyte replacement 7
- Other antiretrovirals, chemotherapy agents, and heavy metals 8
Key clinical clue: If a patient on antiretroviral therapy develops unexplained elevation of alkaline phosphatase (bone-type), immediately check urinary β2-microglobulin and α1-microglobulin to screen for Fanconi syndrome 3.
Management Strategy
Immediate Actions
Discontinue the offending agent if drug-induced. Switching from TDF to tenofovir alafenamide (TAF) results in rapid improvement—urinary markers can normalize within 3 months 3, 6. TAF is substantially safer regarding nephrotoxicity 6.
Replace lost electrolytes and volume aggressively:
Disease-Specific Treatment
For tyrosinemia type I with Fanconi syndrome:
- Initiate NTBC (nitisinone) immediately with dietary restriction of phenylalanine/tyrosine
- The tubulopathy reverses within weeks in nearly all cases with this treatment 2
- Continue lifelong NTBC to prevent irreversible renal damage from succinylacetone accumulation 2
For cystinosis:
- Cysteamine therapy is disease-modifying and should be started promptly 5
Managing Severe Polyuria
For debilitating polyuria (>5L/day) in idiopathic Fanconi syndrome with preserved kidney function:
- Indomethacin at 2 mg/kg/day divided in two doses can reduce urine output by 50% and decrease sodium wasting substantially 9
- Monitor eGFR closely (may drop temporarily but often stabilizes)
- This is particularly valuable when polyuria severely impacts quality of life and academic/work performance 9
Monitoring and Long-term Surveillance
For tyrosinemia patients on NTBC:
- Periodic urinalysis for amino acids, glucose, phosphate, and protein to assess tubular function recovery 2
- Post-liver transplant patients require ongoing renal surveillance as succinylacetone production continues from kidneys 2
For drug-induced cases:
- Symptoms typically resolve after drug discontinuation, but continue monitoring renal function and electrolytes 3, 7
- Some patients may require prolonged or permanent electrolyte supplementation 7
Common Pitfall to Avoid
Do not confuse Fanconi syndrome with refeeding syndrome in malnourished patients presenting with hypophosphatemia. Perform urinalysis showing glucosuria and urine electrolyte losses to distinguish renal Fanconi syndrome from refeeding syndrome 10. The presence of glucosuria with normal serum glucose is the key differentiator.